M. Tamura et al., Induction of angiotensin II subtype 2 receptor-mediated blood pressure regulation in synthetic diet-fed rats, J HYPERTENS, 18(9), 2000, pp. 1239-1246
Citations number
33
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective Chronic feeding of a purified synthetic diet induces renin-angiot
ensin system-dependent moderate high blood pressure in normal Sprague-Dawle
y rats. The present study was designed to characterize the angiotensin II (
Ang II) receptor type 2 (AT(2))-specific mechanism of blood pressure regula
tion in these rats.
Methods The effect of the AT(2) receptor antagonist PD123319 (PD) on blood
pressure was examined in vivo in synthetic diet-fed rats. Ang Ii-dependent
contraction of aortic rings prepared from the synthetic diet-fed rats was a
lso investigated.
Results After 8 weeks of feeding the synthetic diet, the mean arterial pres
sure (MAP) was significantly elevated above levels measured in control rats
(117 +/- 2 Versus 102 +/- 3 mmHg, P < 0.05). Intravenous administration of
PD to conscious hypertensive rats elicited an immediate dose-dependent inc
rease in MAP that was sustained for approximately 7.4 min with 3 mg/kg PD,
The angiotensin converting enzyme inhibitor captopril, but not the Ang II t
ype 1 receptor blocker losartan, significantly attenuated the effect of PD
on blood pressure. PD did not increase the plasma level of catecholamines,
The PD-dependent blood pressure increase was not observed in normotensive c
ontrol rats. Aortic ring assays revealed that functional activation of the
AT(2) receptor occurs only in the hypertensive rats, and this AT(2) respons
e is abolished by indomethacin (5 mu mol/l) but not by N-omega-nitro-L-argi
nine methyl ester (100 mu mol/l).
Conclusion These results clearly demonstrate that AT(2) receptor-mediated b
lood pressure regulation is functional in this experimental model of hypert
ension. Furthermore, cyclooxygenase metabolites might be the key mediators
for the AT(2) receptor-mediated blood pressure-lowering action. JHypertens
2000, 18:1239-1246 (C) Lippincott Williams & Wilkins.